跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,133 条关于
“GluN2B-containing NMDA receptors”
全部
10,133
临床试验
6,198
药物
828
机构
9
资讯
3,098
前天
J&J's CAPLYTA (lumateperone) Meets Primary Endpoint in Pivotal Phase 3 Bipolar I Mania Study
去年
NMDA Receptor Research Reveals Novel Mechanism for Brain Stabilization and Potential Depression Treatments
去年
Ousia Pharma Secures Seed Financing from Omega Funds to Develop Novel Obesity Treatment Targeting NMDA Receptors
去年
IQVIA Gains CDSCO Panel Approval for Phase III Lumateperone Trial in Pediatric Bipolar Depression
去年
GRIN Therapeutics Initiates Radiprodil Trial for Seizures in TSC and FCD
2年前
Radiprodil Shows Promise in Reducing Seizure Frequency in GRIN-Related Neurodevelopmental Disorder
去年
Seyltx Advances Chronic Cough Pipeline with Optimized Ifenprodil Dosing and Strategic NeurOp Partnership
去年
GRIN Therapeutics Secures $140M Series D and Global Partnership with Angelini Pharma for Radiprodil Development
去年
Sage Therapeutics' Alzheimer's Drug Fails in Phase 1 Trial After Parkinson's Setback
2年前
Enzalutamide and Radium-223 Combo Improves Survival in Metastatic Prostate Cancer
第 1 页，共 310 页
上一页
下一页
